Clinical Trial Update: Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects [Phase 1, Phase 2]

View source ↗

Summary

This update reports the completion of Phase 1 and Phase 2 trials evaluating intra-articular delivery of tgAAC94 for inflammatory arthritis, including rheumatoid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Psoriatic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• tgAAC94

Snippet

Sponsor: Targeted Genetics Corporation | Conditions: Arthritis, Rheumatoid, Arthritis, Psoriatic | Phase 1, Phase 2 | Status: COMPLETED